Western blots confirmed downregulation of SRC/YAP1 and SRC/RHOA signaling axis in the DAB2 downregulation cells, and validated tumor growth inhibition of DAB2 (Fig. 7E). The gene discussed is YAP1; the disease is neoplasm.